PTC Therapeutics Inc. logo

PTC Therapeutics Inc.

PTCT | NASDAQ
Chart Builder DCF Calculator
$66.18
+$0.92 (+1.41%)
Sep 22, 2026, 10:48 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
682.64M -363.3M -626.6M -559.02M -523.9M -438.16M
Depreciation & Amortization
38.82M 75.66M 236.59M 128.84M 64.13M 84.87M
Stock-Based Compensation
74.55M 74.62M 131.21M 110.33M 103.51M 70.33M
Other Working Capital
16.17M 94.65M 5.72M -57.74M -4.01M -8.03M
Other Non-Cash Items
-36.93M 58.7M 151.32M 82.81M 128.33M 46.11M
Deferred Income Tax
-3K -55.91M -46.93M -34.28M 377K 5.87M
Change in Working Capital
-47.88M 102.54M -4M -85.34M -23.79M 36.91M
Operating Cash Flow
711.2M -107.69M -158.42M -356.65M -251.33M -194.07M
Capital Expenditures
-8.86M -74.25M -120.62M -152.46M -85.33M -55.98M
Cash Acquisitions
70K n/a n/a 128.44M 57.12M 38.13M
Purchase of Investments
-1.42B -667.36M -212.48M -75.55M -543.27M -1.45B
Sales Maturities Of Investments
855.12M 607.74M 156.37M 518.19M 847.78M 944.09M
Other Investing Acitivies
n/a 110.31M -92.18M -128.44M -57.12M -38.13M
Investing Cash Flow
-861.98M 44.18M -176.74M 290.18M 219.18M -561.55M
Debt Repayment
n/a -1.49M -301.38M 148.72M -2.22M -46.16M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
232.05M 257.36M 947.78M -30.77M n/a 686.79M
Financial Cash Flow
331.09M 255.87M 646.4M 167.95M 20.88M 668.72M
Net Cash Flow
204.94M 185.03M 314.36M 98.71M -19.09M -79.22M
Free Cash Flow
702.34M -181.94M -279.04M -509.11M -336.66M -250.05M
Adj. Free Cash Flow
627.79M -256.55M -410.24M -619.45M -440.18M -320.37M
Maintenance CapEx
n/a -74.25M -73.24M -120.83M -57.27M -44.52M
Growth CapEx
-8.86M n/a -47.38M -31.63M -28.06M -11.45M
Owner Earnings
711.2M -181.94M -231.65M -477.49M -308.6M -238.6M

© 2026 bestshares.com. All rights reserved.